This report contains market size and forecasts of Pharmaceutical Asset Performance Management (APM) in Global, including the following market information:
Global Pharmaceutical Asset Performance Management (APM) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pharmaceutical Asset Performance Management (APM) market was valued at 112.2 million in 2020 and is projected to reach US$ 136.7 million by 2027, at a CAGR of 5.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Asset Performance Management (APM) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Asset Performance Management (APM) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pharmaceutical Asset Performance Management (APM) Market Segment Percentages, By Type, 2020 (%)
Asset Integrity Management
Asset Reliability Management
Other
China Pharmaceutical Asset Performance Management (APM) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pharmaceutical Asset Performance Management (APM) Market Segment Percentages, By Application, 2020 (%)
Large Enterprises
SMEs
Global Pharmaceutical Asset Performance Management (APM) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pharmaceutical Asset Performance Management (APM) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pharmaceutical Asset Performance Management (APM) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pharmaceutical Asset Performance Management (APM) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
GE (US)
Rockwell Software (US)
AVEVA Group plc (UK)
Bentley Systems (US)
AspenTech (US)
Nexus Global (US)
SAP (Germany)
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical Asset Performance Management (APM) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical Asset Performance Management (APM) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical Asset Performance Management (APM) Overall Market Size
2.1 Global Pharmaceutical Asset Performance Management (APM) Market Size: 2021 VS 2027
2.2 Global Pharmaceutical Asset Performance Management (APM) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical Asset Performance Management (APM) Players in Global Market
3.2 Top Global Pharmaceutical Asset Performance Management (APM) Companies Ranked by Revenue
3.3 Global Pharmaceutical Asset Performance Management (APM) Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical Asset Performance Management (APM) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pharmaceutical Asset Performance Management (APM) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical Asset Performance Management (APM) Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical Asset Performance Management (APM) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical Asset Performance Management (APM) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceutical Asset Performance Management (APM) Market Size Markets, 2021 & 2027
4.1.2 Asset Integrity Management
4.1.3 Asset Reliability Management
4.1.4 Other
4.2 By Type - Global Pharmaceutical Asset Performance Management (APM) Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2021
4.2.2 By Type - Global Pharmaceutical Asset Performance Management (APM) Revenue, 2022-2027
4.2.3 By Type - Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical Asset Performance Management (APM) Market Size, 2021 & 2027
5.1.2 Large Enterprises
5.1.3 SMEs
5.2 By Application - Global Pharmaceutical Asset Performance Management (APM) Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2021
5.2.2 By Application - Global Pharmaceutical Asset Performance Management (APM) Revenue, 2022-2027
5.2.3 By Application - Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pharmaceutical Asset Performance Management (APM) Market Size, 2021 & 2027
6.2 By Region - Global Pharmaceutical Asset Performance Management (APM) Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2021
6.2.2 By Region - Global Pharmaceutical Asset Performance Management (APM) Revenue, 2022-2027
6.2.3 By Region - Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2027
6.3.2 US Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.3.3 Canada Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.3.4 Mexico Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2027
6.4.2 Germany Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4.3 France Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4.4 U.K. Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4.5 Italy Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4.6 Russia Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4.7 Nordic Countries Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.4.8 Benelux Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2027
6.5.2 China Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.5.3 Japan Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.5.4 South Korea Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.5.5 Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.5.6 India Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2027
6.6.2 Brazil Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.6.3 Argentina Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical Asset Performance Management (APM) Revenue, 2016-2027
6.7.2 Turkey Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.7.3 Israel Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.7.4 Saudi Arabia Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
6.7.5 UAE Pharmaceutical Asset Performance Management (APM) Market Size, 2016-2027
7 Players Profiles
7.1 GE (US)
7.1.1 GE (US) Corporate Summary
7.1.2 GE (US) Business Overview
7.1.3 GE (US) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.1.4 GE (US) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.1.5 GE (US) Key News
7.2 Rockwell Software (US)
7.2.1 Rockwell Software (US) Corporate Summary
7.2.2 Rockwell Software (US) Business Overview
7.2.3 Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.2.4 Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.2.5 Rockwell Software (US) Key News
7.3 AVEVA Group plc (UK)
7.3.1 AVEVA Group plc (UK) Corporate Summary
7.3.2 AVEVA Group plc (UK) Business Overview
7.3.3 AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.3.4 AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.3.5 AVEVA Group plc (UK) Key News
7.4 Bentley Systems (US)
7.4.1 Bentley Systems (US) Corporate Summary
7.4.2 Bentley Systems (US) Business Overview
7.4.3 Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.4.4 Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.4.5 Bentley Systems (US) Key News
7.5 AspenTech (US)
7.5.1 AspenTech (US) Corporate Summary
7.5.2 AspenTech (US) Business Overview
7.5.3 AspenTech (US) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.5.4 AspenTech (US) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.5.5 AspenTech (US) Key News
7.6 Nexus Global (US)
7.6.1 Nexus Global (US) Corporate Summary
7.6.2 Nexus Global (US) Business Overview
7.6.3 Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.6.4 Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.6.5 Nexus Global (US) Key News
7.7 SAP (Germany)
7.7.1 SAP (Germany) Corporate Summary
7.7.2 SAP (Germany) Business Overview
7.7.3 SAP (Germany) Pharmaceutical Asset Performance Management (APM) Major Product Offerings
7.4.4 SAP (Germany) Pharmaceutical Asset Performance Management (APM) Revenue in Global (2016-2021)
7.7.5 SAP (Germany) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pharmaceutical Asset Performance Management (APM) Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical Asset Performance Management (APM) Market Drivers in Global Market
Table 3. Pharmaceutical Asset Performance Management (APM) Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical Asset Performance Management (APM) in Global Market
Table 5. Top Pharmaceutical Asset Performance Management (APM) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pharmaceutical Asset Performance Management (APM) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pharmaceutical Asset Performance Management (APM) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pharmaceutical Asset Performance Management (APM) Product Type
Table 9. List of Global Tier 1 Pharmaceutical Asset Performance Management (APM) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical Asset Performance Management (APM) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type